Biogen Inc. Common Stock (BIIB)
Publicly reported company facts and saved market data for Biogen Inc. Common Stock (BIIB), with sources and as-of times. Saved data is not a live quote.
Company profile
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients' lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
Company facts
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Market cap
- $37.5B · as of
- Incorporated in
- United States
- Company website
- www.biogen.com
- Exchange
- NASDAQ
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $253.6
- Reported change
- +1.58%
- Reported volume
- 1,303,054
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float F01 | 147,502,818 | Reported by a single source; not cross-checked. | |
| Historical float F02 | 1,021,015,850 | Historical estimate from the SEC-disclosed public float value; not current tradable shares. | |
| Shares outstanding (O/S) | 147,637,117 | SEC 10-Q filing · filed |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Short interest
- Reported short interest
- 5,500,386 shares
- Settlement date
- Source
- Market and company data
Exchange-published short interest for the stated settlement date, not a live short position.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 250.35 | 253.98 | 248.46 | 252.73 | 1,393,391 | |
| 251.02 | 254.11 | 249.61 | 252.26 | 958,847 | |
| 251.68 | 252.44 | 246.15 | 250.69 | 1,157,376 | |
| 240.61 | 254.41 | 240.02 | 253.84 | 2,237,991 | |
| 242.02 | 243.32 | 240.13 | 240.98 | 812,898 | |
| 236.79 | 244.65 | 235.96 | 243.10 | 1,492,300 | |
| 231.81 | 236.00 | 231.04 | 233.48 | 949,716 | |
| 235.75 | 236.87 | 232.36 | 232.65 | 1,462,717 | |
| 236.46 | 240.99 | 235.22 | 235.35 | 1,572,453 | |
| 228.99 | 234.20 | 228.00 | 232.83 | 1,947,327 |
Dilution timeline
As of
- · S-3ASR · Shelf registration filed
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue